Our editorial team sees Peak Wellness as a promising but unproven entrant
Month two often includes refining your strength routine, expanding your meal options, and setting new targets based on your progress
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss The digital health platforms new GLP-1 Rx program pairs microdosed weight-loss drugs with biomarker testing and behavior change to target early metabolic risk For consumers intrigued by the promise of GLP-1 medications but who dont meet the BMI requirements typically tied to prescriptions, the door has largely stayed closed until now
If you have a BMI of 22 or higher, you may be an eligible candidate for the GLP-1 Microdose Protocol
Some individuals may experience digestive side effects when starting GLP-1 therapy, including nausea, bloating, early fullness, constipation, or loose stools